EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Biological Evaluation of Proteolysis-Targeting Chimeras as Highly Selective and Efficient Degraders of Extracellular Signal-Regulated Kinase 5

Pengming Pan, Tongtong Geng, Zhongtang Li, Xuyang Ding, Mengyuan Shi, Yang Li, Yashuai Wang, Yuanyuan Shi, Jiaojiao Wu, Liang Zhong, Dengbo Ji, Zhongjun Li iD und 1 weitere

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.3c00864 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Pengming Pan und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Hauptthemen laut MEDLINE: Proteolysis, Drug Design, Mitogen-Activated Protein Kinase 7, Protein Kinase Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular signal-regulated kinase 5 (ERK5) is recognized as a key member of the mitogen-activated protein kinase family and is involved in tumor growth, migration, and angiogenesis. However, the results of ERK5 inhibition in multiple studies are controversial, and a highly specific ERK5-targeting agent is required to confirm physiological functions. Using proteolysis-targeting chimera technology, we designed the selective ERK5 degrader PPM-3 and examined its biological effect on cancer cells. Interestingly, the selective degradation of ERK5 with PPM-3 did not influence tumor cell growth directly. Based on proteomics analysis, the ERK5 deletion may be associated with tumor immunity. PPM-3 influences tumor development by affecting the differentiation of macrophages. Therefore, PPM-3 is an effective small-molecule tool for studying ERK5 and a promising immunotherapy drug candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteolysisDrug DesignMitogen-Activated Protein Kinase 7Protein Kinase InhibitorsAntineoplastic AgentsHumansAnimalsCell Line, TumorMiceCell Proliferation

Substanzen

Mitogen-Activated Protein Kinase 7Protein Kinase InhibitorsMAPK7 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery III, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.

ORCID-Profile: Zhongjun Li, Xiangbao Meng

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Pan, P., Geng, T., Li, Z., Ding, X., Shi, M., Li, Y., Wang, Y., Shi, Y., Wu, J., Zhong, L., Ji, D., Li, Z., & Meng, X. (2023). Design, Synthesis, and Biological Evaluation of Proteolysis-Targeting Chimeras as Highly Selective and Efficient Degraders of Extracellular Signal-Regulated Kinase 5. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c00864

Vancouver

Pan P, Geng T, Li Z, Ding X, Shi M, Li Y, et al. Design, Synthesis, and Biological Evaluation of Proteolysis-Targeting Chimeras as Highly Selective and Efficient Degraders of Extracellular Signal-Regulated Kinase 5. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c00864

BibTeX
@article{Pan2023,
  author = {Pan, Pengming and Geng, Tongtong and Li, Zhongtang and Ding, Xuyang and Shi, Mengyuan and Li, Yang and Wang, Yashuai and Shi, Yuanyuan and Wu, Jiaojiao and Zhong, Liang and Ji, Dengbo and Li, Zhongjun and Meng, Xiangbao},
  title = {Design, Synthesis, and Biological Evaluation of Proteolysis-Targeting Chimeras as Highly Selective and Efficient Degraders of Extracellular Signal-Regulated Kinase 5},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.3c00864}
}
Kostenlos starten →